Development and Evaluation of Rutin-HPβCD Inclusion Complex Based Mouth Dissolving Tablets
@inproceedings{Bhalkar2018DevelopmentAE,
title={Development and Evaluation of Rutin-HP$\beta$CD Inclusion Complex Based Mouth Dissolving Tablets},
author={Hitendra S Mahajan and Krishna G Bhalkar},
year={2018}
}The objective of the present study was to explore inclusion complex of Rutin to improve the aqueous solubility and dissolution rate along with rapid mouth dissolving tablets for oral drug delivery.
4 Citations
. Preparation and Characterization of Atorvastatin Calcium Trihydrate-cyclodextrin Inclusion Complex
- BiologyINTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY
- 2022
Atorvastatin calcium (ATR) is an antihyperlipidemic agent used for lowering blood cholesterol levels. However, it is very slightly soluble in water with poor oral bioavailability, which interferes…
Physico-Chemical and Pharmaco-Technical Characterization of Inclusion Complexes Formed by Rutoside with β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Used to Develop Solid Dosage Forms
- ChemistryProcesses
- 2020
The aim of our study was to obtain rutoside (RUT) inclusion complexes in β-cyclodextrin (β-CD) and in hydroxypropyl-β-cyclodextrin (HP-β-CD), in a 1:1 molar ratio, using the lyophilization method of…
A Mechanistic Insight on Phytoconstituents Delivering Hypoglycemic Activity: A Comprehensive Overview
- Biology, MedicineFuture Pharmacology
- 2022
Information is presented concerning well researched phytoconstituents established as potential hypoglycemic agents for the prevention and treatment of diabetes and its associated disorders having restricted solubility and bioavailability related issues.
Development and Evaluation of Rutin-HPβCD Inclusion Complex Based Mouth Dissolving Tablets
- Geology
- 2018
The objective of the present study was to explore inclusion complex of Rutin to improve the aqueous solubility and dissolution rate along with rapid mouth dissolving tablets for oral drug delivery.
References
SHOWING 1-10 OF 25 REFERENCES
Preformulation Study of the Inclusion Complex Irbesartan-β-Cyclodextrin
- Materials ScienceAAPS PharmSciTech
- 2009
The study indicated the usefulness of cyclodextrin technology to overcome the solubility problem of IRB and coevaporation was the best in which thesolubility was increased and dissolution rate of the drug was the highest.
Improvement of Dissolution Characteristics of Meloxicam by Complexation with Cyclodextrins
- Chemistry
- 2011
The aim of the present study was an attempt to prepare tablets containing inclusion complexes of meloxicam with β-cyclodextrins and hydroxypropyl-β-cyclodextrin to improve the aqueous solubility of…
Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
- Chemistry, MedicineEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
- 1998
Characterization of Cyclodextrin Inclusion Complexes - A Review
- Chemistry, Biology
- 2010
A critical review of the literature was carried out to characterize the formation of inclusion complexes by different techniques in the solid and in the solution state to determine the interaction of drug molecules with cyclodextrins which confirm the formationof inclusion complexes.
Synthesis and Characterization of the Inclusion Complex of β-cyclodextrin and Azomethine
- ChemistryInternational journal of molecular sciences
- 2013
The product was characterized by Fourier Transform Infrared spectrometer, 1H Nuclear Magnetic Resonance and Thermogravimetric Analyzer, which proves the formation of the inclusion complex where the benzyl part of azomethine has been encapsulated by the hydrophobic cavity of β-Cyd.
Essentials of Pharmaceutical Preformulation
- Medicine
- 2012
Essentials of Pharmaceutical Preformulation is a study guide which describes the basic principles of pharmaceutical physicochemical characterisation and discusses their wider implication for pharmaceutical development, with reference to many case examples of current drugs and drug products.